- Leap Therapeutics press release (NASDAQ:LPTX): Q1 GAAP EPS of -$0.09 beats by $0.01.
- Cash and cash equivalents totaled $103.2 million at March 31, 2022.
- Shares +2.73% PM.
Leap Therapeutics GAAP EPS of -$0.09 beats by $0.01
Recommended For You
More Trending News
About LPTX Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
LPTX | - | - |
Leap Therapeutics, Inc. |